AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Tours
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of the 12-week retention rate of patients randomised to CBT compared with patients in the 'treatment as usual' control arm. In order to meet the objective, the patient will take part in a standardized assessment, followed by a therapeutic intervention and a new standardized assessment after the intervention. The standardized assessment consists as follows : * firstly, 7 self-questionnaires to be completed by the patient, lasting around 45 min, aimed at assessing his or her socio-demographic data; current symptoms, quality of life and functional impact related to ADHD; impulsivity, emotion regulation and assessment of possible anxiety-depressive disorders. * Then the

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient over 18 (age โ‰ฅ 18 years) * Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity * Patient affiliated to a social security scheme * For patients treated with methylphenidate: no change in treatment dosage during the previous three months. * For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months. Exclusion Criteria: * Patients with psychotic disorders (assessed by clinician) * Pregnant or breast-feeding women * Patients under protective supervision (guardianship or curatorship) * Persons under court protection * Persons deprived of their liberty * Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment). * Physical inability to participate in CBT sessions (e.g., lack of telephone, foreseeable unavailability). * Difficulty understanding self-questionnaires, including illiteracy. * Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome.
๐Ÿ’Š

What it tests

  • Cognitive behavioral therapy
๐Ÿ“

Where

3 sites
CHU La Cavale Blanche
Brest, France
Centre Hospitalier Saint Jacques
Nantes, France
CHRU De Tours
Tours, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy